Table 2 Proportion influenza and RSV positive by GBD super-region
From: Hospital utilization rates for influenza and RSV: a novel approach and critical assessment
GBD super region | Age | Influenza positive proportion of ALRI admissions (95% UI) | RSV positive proportion of ALRI admissions (95% UI) |
|---|---|---|---|
Central Europe, Eastern Europe, and Central Asia | < 1 year | 0.06 (0.01–0.25) | 0.39 (0.14–0.72) |
Central Europe, Eastern Europe, and Central Asia | 1 to 4 | 0.08 (0.01–0.31) | 0.24 (0.07–0.55) |
Central Europe, Eastern Europe, and Central Asia | 5 to 17 | 0.22 (0.03–0.63) | 0.08 (0.02–0.23) |
Central Europe, Eastern Europe, and Central Asia | 18 to 49 | 0.26 (0.04–0.68) | 0.03 (0.01–0.1) |
Central Europe, Eastern Europe, and Central Asia | 50 to 64 | 0.1 (0.01–0.35) | 0.01 (0–0.03) |
Central Europe, Eastern Europe, and Central Asia | 65 plus | 0.02 (0–0.09) | 0 (0–0.01) |
High-income | < 1 year | 0.06 (0.01–0.23) | 0.36 (0.12–0.68) |
High-income | 1 to 4 | 0.08 (0.01–0.29) | 0.22 (0.06–0.51) |
High-income | 5 to 17 | 0.21 (0.03–0.62) | 0.07 (0.02–0.2) |
High-income | 18 to 49 | 0.25 (0.04–0.67) | 0.03 (0.01–0.08) |
High-income | 50 to 64 | 0.09 (0.01–0.34) | 0.01 (0–0.03) |
High-income | 65 plus | 0.02 (0–0.08) | 0 (0–0.01) |
Latin America and Caribbean | < 1 year | 0.05 (0–0.19) | 0.43 (0.16–0.76) |
Latin America and Caribbean | 1 to 4 | 0.06 (0.01–0.24) | 0.27 (0.08–0.6) |
Latin America and Caribbean | 5 to 17 | 0.18 (0.02–0.56) | 0.09 (0.02–0.26) |
Latin America and Caribbean | 18 to 49 | 0.21 (0.03–0.62) | 0.03 (0.01–0.11) |
Latin America and Caribbean | 50 to 64 | 0.07 (0.01–0.29) | 0.01 (0–0.04) |
Latin America and Caribbean | 65 plus | 0.01 (0–0.07) | 0 (0–0.01) |
North Africa and Middle East | < 1 year | 0.05 (0–0.19) | 0.32 (0.1–0.66) |
North Africa and Middle East | 1 to 4 | 0.06 (0.01–0.25) | 0.19 (0.05–0.48) |
North Africa and Middle East | 5 to 17 | 0.18 (0.02–0.56) | 0.06 (0.01–0.18) |
North Africa and Middle East | 18 to 49 | 0.21 (0.03–0.61) | 0.02 (0–0.07) |
North Africa and Middle East | 50 to 64 | 0.07 (0.01–0.29) | 0.01 (0–0.03) |
North Africa and Middle East | 65 plus | 0.02 (0–0.07) | 0 (0–0) |
South Asia | < 1 year | 0.04 (0–0.18) | 0.33 (0.1–0.67) |
South Asia | 1 to 4 | 0.06 (0.01–0.23) | 0.19 (0.05–0.49) |
South Asia | 5 to 17 | 0.17 (0.02–0.54) | 0.06 (0.01–0.18) |
South Asia | 18 to 49 | 0.2 (0.03–0.59) | 0.02 (0–0.07) |
South Asia | 50 to 64 | 0.07 (0.01–0.27) | 0.01 (0–0.03) |
South Asia | 65 plus | 0.01 (0–0.06) | 0 (0–0) |
Southeast Asia, East Asia, and Oceania | < 1 year | 0.08 (0.01–0.29) | 0.31 (0.1–0.64) |
Southeast Asia, East Asia, and Oceania | 1 to 4 | 0.1 (0.01–0.36) | 0.19 (0.05–0.46) |
Southeast Asia, East Asia, and Oceania | 5 to 17 | 0.26 (0.04–0.68) | 0.06 (0.01–0.17) |
Southeast Asia, East Asia, and Oceania | 18 to 49 | 0.3 (0.05–0.73) | 0.02 (0–0.07) |
Southeast Asia, East Asia, and Oceania | 50 to 64 | 0.11 (0.01–0.41) | 0.01 (0–0.02) |
Southeast Asia, East Asia, and Oceania | 65 plus | 0.03 (0–0.11) | 0 (0–0) |
Sub-Saharan Africa | < 1 year | 0.04 (0–0.16) | 0.42 (0.15–0.75) |
Sub-Saharan Africa | 1 to 4 | 0.05 (0–0.21) | 0.27 (0.08–0.59) |
Sub-Saharan Africa | 5 to 17 | 0.15 (0.02–0.49) | 0.09 (0.02–0.26) |
Sub-Saharan Africa | 18 to 49 | 0.18 (0.02–0.55) | 0.03 (0.01–0.11) |
Sub-Saharan Africa | 50 to 64 | 0.06 (0.01–0.24) | 0.01 (0–0.04) |
Sub-Saharan Africa | 65 plus | 0.01 (0–0.06) | 0 (0–0.01) |